Vaccines may not be able to ward off long Covid risk, finds study

Previous studies claimed that vaccination, which remains critically important in the fight against Covid-19, wards off the long Covid risk

vaccine
IANS Washington
2 min read Last Updated : Aug 01 2023 | 5:54 PM IST

Even vaccinated people with mild breakthrough Covid-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to new research.

Previous studies claimed that vaccination, which remains critically important in the fight against Covid-19, wards off the long Covid risk. Yet the study found long Covid risks to be higher among people who are unvaccinated.

The study, published in the journal Nature Medicine, showed that long Covid risks were 17 per cent higher among vaccinated immunocompromised people with breakthrough infections compared with previously healthy, vaccinated people who experienced breakthrough infections.

But, compared with unvaccinated patients infected with the virus, vaccination were found to reduce the risk of death by 34 per cent and the risk of getting long Covid by 15 per cent, said researchers at Washington University in St. Louis.

The findings also showed vaccines to be most effective in preventing some of the most worrisome manifestations of long Covid - lung and blood-clotting disorders - which declined about 49 per cent and 56 per cent, respectively, among those who were vaccinated.

"Vaccinations reduce the risk of hospitalisation and dying from Covid-19. But vaccines seem to only provide modest protection against long Covid. People recovering from breakthrough Covid-19 infection should continue to monitor their health and see a health-care provider if lingering symptoms make it difficult to carry out daily activities," said first author Ziyad Al-Aly, a clinical epidemiologist at the Washington University.

Al-Aly stressed the need to "urgently develop and deploy additional layers of protection that could be sustainably implemented to reduce the risk of long Covid".

Such protective layers could include nasal vaccines that are more convenient or potent than the current shots, or other types of vaccines or drugs aimed at minimising the risks of long Covid.

For the study, researchers examined data of 113,474 unvaccinated Covid-19 patients and 33,940 vaccinated patients who had experienced Covid-19 breakthrough infections, all from January 1 through October 31, 2021.

A further analysis of 3,667 vaccinated patients who were hospitalised with breakthrough Covid-19 infections showed that they had a 27 per cent higher risk of long Covid in the first 30 days after diagnosis compared with 14,337 people who were hospitalised with seasonal influenza.

--IANS

rvt/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccinepublic health

First Published: May 26 2022 | 2:17 PM IST

Next Story